AzTrials
AzTrials

Maternal HealthNCT05802615

Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial

A study testing PARITY in people with Maternal Health and Blood Pressure, run by University of Nebraska at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. Read more about this study

Who is it for?
Ages 19 to 51 years, women onlyHealthy volunteers can take part
Conditions the study is for
Maternal Health, Blood Pressure
What is being tested?
PARITY
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteUnited States
Study dates
6 Apr 2023to 6 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 51 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Black race
  • Pregnant with gestational age 20-28 weeks at enrollment
  • Ability to read and write in English language
  • Planning to give birth at a healthcare facility \& receive obstetrical care with a healthcare record
  • Reside within 20 minutes of the Lincoln/Omaha, NE metro area
  • Owns a smartphone with internet access

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Nebraska Medical Center

    Omaha, Nebraska, 68198

Other trials in United States

About this study

This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness.

Read the detailed description

The overall objective of this study is to determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness (sleep, physical activity, nutrition, prenatal care adherence) in Black pregnant women.

Being tested
PARITY, Usual Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PARITYBehavioural

    The PARITY program reinforces strengths through consistent, community-based Black doula support and protective asset (personal strengths) focused messaging. PARITY promotes wellness-related behaviors (nutrition, physical activity, sleep, and healthcare adherence) and promotes and builds empowered strengths (self-efficacy, social support, motivation, resilience, problem-solving, and self-regulation) through mobile technology and doula support.

  • Usual CareOther

    Participants will obtain prenatal care from their usual care provider and a handout on healthy pregnancy.

Study groups in NCT05802615
Study groupRoleWhat they receive
PARITYExperimentalParticipants will take part in the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program which is community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths through positive messaging and by promoting wellness (sleep, physical activity, nutrition, prenatal care adherence) in Black pregnant women.
Receives: Behavioral: PARITY; Other: Usual Care
ControlPlacebo comparatorParticipants will obtain prenatal care from their usual care provider and a handout on healthy pregnancy.
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal Blood Pressure

    Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110).

    Measured: 20 weeks

  2. Maternal Blood Pressure

    Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110).

    Measured: 36 weeks

  3. Maternal Blood Pressure

    Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110).

    Measured: Birth (approximately 36-42 weeks)

  4. Maternal Blood Pressure

    Participant blood pressure (systolic and diastolic) (continuous) as well as blood pressure classifications hypertension (>140/90); Severe hypertension (>160/110).

    Measured: 6-12 weeks postpartum

  5. Feasibility, Enrollment

    Percentage of eligible individuals who agree to participate in the trial

    Measured: Baseline

  6. Feasibility, Attrition

    Percentage of eligible individuals who complete the data

    Measured: Completion of Study (~24 months)

  7. Feasibility, Adherence

    Number of intervention sessions completed by study participants

    Measured: Completion of Study (~24 months)

Secondary outcomes (2)
  1. Gestational Weight Gain

    Amount of weight gained in pounds

    Measured: 20 weeks, 36 weeks, Birth, 6 weeks postpartum.

  2. Delivery Modality

    Modality of birth (Vaginal, Cesarean, Assisted Vaginal delivery)

    Measured: Birth (approximately 36-42 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2023
  2. Study start6 Apr 2023
  3. Primary completion6 Aug 2025
  4. Study completion6 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05802615
Sponsor's protocol ID
0076-23-EP
Status last verified
Dec 2024
First submitted
19 Mar 2023
Last updated
10 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mollard E, Cooper Owens D, Bach C, Gaines C, Maloney S, Moore T, Wichman C, Shah N, Balas M. Protective Assets Reinforced With Integrated Care and Technology (PARITY): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Aug 8;13:e58580. doi: 10.2196/58580.

    PubMed 39116423

Questions about this trial

What is this clinical trial studying?

A study testing PARITY in people with Maternal Health and Blood Pressure, run by University of Nebraska at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal Blood Pressure (time frame: 20 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05802615, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in